Skip to search formSkip to main contentSkip to account menu

GM2-KLH vaccine/QS21

Known as: GM2-KLH/QS-21, GM2-KLH/QS21, GMK 
A cancer vaccine based on the immunogenic ganglioside GM2, The GM2-KLH Vaccine/QS21 vaccine consists of GM2 conjugated with KLH keyhole limpet… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Experimental studies of arbidol and arbidol mesylate versus ribavirin suggest that insertion of these agents into the nutrient… 
Highly Cited
2001
Highly Cited
2001
PURPOSE Vaccine alternatives to high-dose interferon alfa-2b therapy (HDI), the current standard adjuvant therapy for high-risk… 
Highly Cited
2001
Highly Cited
2001
PURPOSE High-dose interferon alfa-2b (IFNalpha2b) is the only established adjuvant therapy of resectable high-risk melanoma. GM2… 
Highly Cited
2000
Highly Cited
2000
In a previous randomized Phase III trial (P. O. Livingston et al, J. Clin. Oncol., 12: 1036-1044, 1994), we demonstrated that… 
Review
1999
Review
1999
Abstract The positive impact on survival of traditional chemotherapeutic agents has renewed interest in developing newer… 
Highly Cited
1994
Highly Cited
1994
Attachment and entry of coxsackievirus A9 (CAV-9) to GMK cells were previously shown to be dependent on an arginine-glycine… 
Highly Cited
1986
Highly Cited
1986
Herpes simplex virus type 1 and a fluorescein-labelled lectin (wheat germ agglutinin) were selectively transported to nerve cell… 
Highly Cited
1966
Highly Cited
1966
ALTHOUGH the need for an effective, safe rubella-virus vaccine has long been recognized it was not until 1962, when the virus was…